期刊文献+

维生素C诱导人宫颈癌Caski细胞凋亡及其分子机制的研究 被引量:4

Molecular Mechanism of Vitamin C on Proliferation and Apoptosis of Human Cervical Cancer Cell Lines Caski in vivo
暂未订购
导出
摘要 为了研究维生素C对人宫颈癌Caski细胞体外抑制、诱导凋亡的作用及其分子机制,使用不同剂量维生素C处理人宫颈癌Caski细胞,采用噻唑蓝(MTT)法检测药物对细胞增殖的抑制作用;流式细胞仪检测Cas-ki细胞周期变化;琼脂糖电泳法观察凋亡细胞DNA Ladder现象;Western blot检测凋亡相关蛋白Bcl-2、Bax和E6的表达以及Caspase 3的激活;荧光染色观察细胞线粒体膜电位的改变.分析发现,维生素C可显著抑制人宫颈癌Caski细胞增殖,呈现明显的时间和剂量依赖性;将细胞阻滞于S期;诱导细胞凋亡,下调Bcl-2和E6、上调Bax蛋白表达,促进Caspase3活化,降低线粒体膜电位.表明维生素C在体外可有效抑制人宫颈癌Caski细胞增殖,诱导细胞凋亡. To study the effects of Vitamin C on proliferation and apoptosis of human cervical cancer cell lines Caski in vivo. Caski cell was treated with different concentrations of Vitamin C in vitro. MTT was used for the analysis of cell proliferation, the flow cytometry was performed to assay cell cycles and DNA fragmentation assay was used to identify apoptotic cells, Western blot was used to evaluate the expression of apoptosis-related protein Bcl-2, Bax, E6 and Caspase 3, fluorescent dye assay was performed to determine the changes in mitochondrial membrane potential. Vitamin C treatment inhibited the proliferation of Caski cells significantly in a dosage- and time-dependent manner. The results from flow cytometry analysis indicated that Vitamin C interfered with cell cycles and increased cell percentage in S phase, at the same time, the number of apoptotic cells increased significantly. After Vitamin C treatment, the typical phenomenon for apoptotic cells was observed and the contents of pro-apoptotic protein Bax in the cytosol were significantly increased, but the contents of anti-apoptotic protein Bcl-2 and E6 and caspase 3 were down-regulated. Vitamin C accompanied by a significant reduction in the mitochondrial membrane potential in Caski cells. The results showed that the Vitamin C inhibits growth and induces apoptosis of Caski cell lines.
出处 《生命科学研究》 CAS CSCD 北大核心 2013年第2期143-147,共5页 Life Science Research
基金 三峡大学青年科学基金资助项目(KJ2008A038)
关键词 维生素C CASKI细胞 凋亡机制 Vitamin C Caski cells apoptosis molecular mechanism
  • 相关文献

参考文献12

  • 1LI Y, SCHELLHORN H E. New developments and novel therapeutic perspectives for vitamin C[J]. The Journal of Nutri- tion, 2007, 137(10): 2171-2184.
  • 2VERRAX J, CALDERON P B. The controversial place of vi- tamin C in cancer treatment[J]. Biochemiacl Pharmacology, 2008,76(12): 1644-1652.
  • 3MIKIROVA N, CASCIARI J, ROGERS A, et aL Effect of high-dose intravenous vitamin C on inflammation in cancer pa- tients[J]. Journal of Translation Medicine, 2012, September 11. doi: 10.1186/1479-5876-10-189.
  • 4OHNO S, OHNO Y, SUZUKI N, et ol. High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with ad- vanced cancer[J]. Anticancer Research, 2009, 29(3): 809-815.
  • 5LEVINE M, PADAYATI'Y S J, ESPEY M G. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries[J]. Advances Nutrition, 2011, 2(2): 78- 88.
  • 6STEPHENSON C M, LEVIN R D, LIS C G. Phase 1 trial of high-dose intravenous vitamin C treatment for patients with cancer[J]. The Journal of the American Osteopathic Association, 2007, 107(6): 212-213.
  • 7CHEN Q, ESPEY M G, KRISHNA M C, et al. Pharmacolog- ic ascorbic acid concentrations selectively kill cancer ceils: action as a pro-drug to deliver hydrogen peroxide to tissues[J]. Proceedings of the National Academy of Sciences of the Unit- ed States of America, 2005, 102(38): 13604-13609.
  • 8ZHENG Q S, ZHANG Y T, ZHENG R L. Ascorbic acid in- duces redifferentiation and growth inhibition in human hep- atoma cells by increasing endogenous hydrogen peroxide[J]. Die Pharmazie, 2002, 57(11): 753-757.
  • 9李能,陈忠东,周波.维生素C体外抑制宫颈癌H eLa细胞株生长及其机制的研究[J].中国药理学通报,2005,21(9):1096-1099. 被引量:10
  • 10JONES D P. Redox sensing: Orthogonal control in cell cycle and apoptosis signaling[J]. Journal of Internal Medicine, 2010, 268(5): 432-448.

二级参考文献26

  • 1Shai A,Brake T,Somoza C,et al.The human Papilloma virus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities[J].Cancer Res,2007,67 (4):1626-1635.
  • 2Xu M,Luo W,Elzi D J,et al.NFX1 interacts with mSin3A /histone deacetylase to repress hTERT transcription iratinocytes[J].Mol Cell Biol,2008,28(15):4819-4828.
  • 3Schwartz T F,Spaczynski M,Schneider A,et al.Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years[J].Vaccine,2009,27:581-587.
  • 4Xu Y F.HPV16 chimeric virus-like particle vaccine with mLTK63adjuvant[J].Basic Clini Med,2008,in press.
  • 5Mark R P,Trent H,Roger D P,et al.Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response[J].PNAS,2006,103(10):3822-3827.
  • 6Zheng QS, Zhang YT, Zheng RL. Ascorbic acid induces redifferentiation and growth inhibition in human hepatoma cells by increasing endogenous hydrogen peroxide[J]. Pharmazie, 2002,57(11):753-7.
  • 7Jamison JM,Gilloteaux J,Taper HS et al. Autoschizis:A novel cell death[J]. Biochem harmacol,2002,63(10):1773-83.
  • 8Ahmed MI,Fayed ST,Hossein H et al.Lipid peroxidation and antioxidant status in human cervical carcinoma[J]. Dis Markers,1999,15(4):283-91.
  • 9Giuliano AR,Siegel EM,Roe DJ et al.Dietary intake and risk of persistent human papillomavirus (HPV) infection: The ludwig-McGill HPV natural history study[J]. J Infect Dis,2003,188(10):1508-16.
  • 10Atalah E,Urteaga C,Rebolledo A et al. Diet,smoking and reproductive history as risk factor for cervical cancer[J]. Rev Med Chil, 2001,129(6):597-603.

共引文献19

同被引文献87

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部